Q4 2024 Holdings
Filed 2025-02-14 | 62 holdings | $1.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $196.6M | 4,549,881 | 13.7% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $118.0M | 753,175 | 8.2% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $79.0M | 4,192,627 | 5.5% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $70.9M | 4,840,463 | 4.9% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $66.5M | 7,054,890 | 4.6% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $59.4M | 4,905,527 | 4.1% |
| Immunome Inc(IMNM) | COM | 45257U108 | $51.3M | 4,828,026 | 3.6% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $50.7M | 4,593,629 | 3.5% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $48.3M | 1,043,539 | 3.4% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $44.3M | 1,100,432 | 3.1% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $38.1M | 2,895,478 | 2.7% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $37.9M | 1,528,567 | 2.6% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $37.1M | 4,794,780 | 2.6% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $34.4M | 1,235,209 | 2.4% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $33.8M | 904,496 | 2.4% |
| Annexon Inc(ANNX) | COM | 03589W102 | $32.3M | 6,300,644 | 2.3% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $31.2M | 15,666,731 | 2.2% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $30.2M | 1,319,763 | 2.1% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $27.9M | 312,683 | 1.9% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $27.7M | 3,554,836 | 1.9% |
| Absci Corporation(ABSI) | COM | 00091E109 | $21.6M | 8,253,316 | 1.5% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $21.2M | 12,872,946 | 1.5% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $18.0M | 2,952,131 | 1.3% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $16.9M | 2,167,176 | 1.2% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $16.5M | 2,399,317 | 1.2% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $15.9M | 619,300 | 1.1% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $15.6M | 615,775 | 1.1% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $14.7M | 320,149 | 1.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $14.2M | 571,824 | 1.0% |
| Ceribell Inc(CBLL) | COM | 15678C102 | $11.3M | 435,239 | 0.8% |
| Stryker Corporation(SYK) | COM | 863667101 | $11.0M | 30,676 | 0.8% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $10.2M | 6,475,317 | 0.7% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $9.5M | 83,471 | 0.7% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $8.8M | 16,943 | 0.6% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $8.7M | 552,506 | 0.6% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $8.1M | 3,031,009 | 0.6% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $8.0M | 1,576,259 | 0.6% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $8.0M | 411,728 | 0.6% |
| Verve Therapeutics Inc | COM | 92539P101 | $7.4M | 1,318,164 | 0.5% |
| Shattuck Labs Inc(STTK) | COM | 82024L103 | $6.7M | 5,539,724 | 0.5% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $6.7M | 1,196,910 | 0.5% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $6.2M | 3,689,611 | 0.4% |
| Penumbra Inc(PEN) | COM | 70975L107 | $6.1M | 25,743 | 0.4% |
| Prime Medicine Inc(PRME) | COM | 74168J101 | $6.1M | 2,074,350 | 0.4% |
| Atara Biotherapeutics Inc(ATRA) | COM NEW | 046513206 | $5.9M | 441,701 | 0.4% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $4.4M | 92,598 | 0.3% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $4.1M | 1,799,465 | 0.3% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $3.6M | 3,015,097 | 0.3% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $3.1M | 346,278 | 0.2% |
| AC Immune SA(ACIU) | SHS | H00263105 | $2.8M | 1,034,299 | 0.2% |